Back to calendar
Halozyme Therapeutics, Inc. (HALO) Earnings
HALO reports earnings on Tuesday, August 11, 2026
earnings report
August 11, 2026 · Before Market Open
Q2 2026
Est. EPS: $1.79
Actual EPS: $1.60
EPS surprise: 3.56%
Company overview
Market Cap$9.6B
PriceUSD 80.75
P/E29.04
EPS (TTM)2.78
52-week high82.26
52-week low57.67
SectorHealth Technology
IndustryBiotechnology
Employees423